Related references
Note: Only part of the references are listed.Regulation of Sodium Iodide Symporter Gene Expression by Rac1/p38β Mitogen-activated Protein Kinase Signaling Pathway in MCF-7 Breast Cancer Cells
Takahiko Kogai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation
Debyani Chakravarty et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer?
S. J. Beyer et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Breast cancer resistance protein/ABCG2 is differentially regulated downstream of extracellular signal-regulated kinase
Yasuo Imai et al.
CANCER SCIENCE (2009)
PI3K activation is associated with intracellular sodium/iodide symporter protein expression in breast cancer
Katherine A. B. Knostman et al.
BMC CANCER (2007)
Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein
Kazuhiro Katayama et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
P. J. Roberts et al.
ONCOGENE (2007)
MEK signaling modulates sodium iodide symporter at multiple levels and in a paradoxical manner
Douangsone D. Vadysirisack et al.
ENDOCRINE-RELATED CANCER (2007)
Hydrocortisone and purinergic signaling stimulate sodium/iodide symporter NIS)-mediated iodide transport in breast cancer cells
O Dohán et al.
MOLECULAR ENDOCRINOLOGY (2006)
The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I- targeting to the membrane
G Riesco-Eizaguirre et al.
ENDOCRINE-RELATED CANCER (2006)
Dexamethasone stimulation of retinoic acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells
S Unterholzner et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Cell surface targeting accounts for the difference in iodide uptake activity between human Na+/I- symporter and rat Na+/I- symporter
ZX Zhang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Differential regulation of sodium/iodide symporter gene expression by nuclear receptor ligands in MCF-7 breast cancer cells
T Kogai et al.
ENDOCRINOLOGY (2005)
MEK-ERK signaling controls Hdm2 oncoprotein expression by regulating hdm2 mRNA export to the cytoplasm
M Phelps et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Application of the Cre/loxP system to enhance thyroid-targeted expression of sodium/iodide symporter
XQ Lin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
The Na+/I- symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid
IL Wapnir et al.
CLINICAL CANCER RESEARCH (2004)
Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections
IL Wapnir et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
The mammary gland iodide transporter is expressed during lactation and in breast cancer
UH Tazebay et al.
NATURE MEDICINE (2000)
Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line
T Kogai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
